Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DJ81QF
|
|||
| Drug Name |
VE303
|
|||
| Drug Type |
Live biotherapeutic product
|
|||
| Indication | Clostridium infection [ICD-11: 1A04; ICD-10: A04.7] | Phase 2 | [1] | |
| Company |
Vedanta Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03788434) Phase 2 Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection (CONSORTIUM). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.